- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
November 10, 2020
[Expression of Hemeoxygenase-1 and clear cell renal cell carcinoma aggressiveness.]
November 10, 2020
Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts.
November 10, 2020
Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
November 9, 2020
MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
November 9, 2020
Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.
November 9, 2020
Identified a Biomarker That Predicts the Increase in Malignancy That Antiangiogenic Therapy Can Cause in Kidney Cancers
November 6, 2020
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma.
November 6, 2020
Association of Hepatitis C Infection and Risk of Kidney Cancer: A Systematic Review and Meta-analysis of Observational Studies.
November 5, 2020
Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma.
November 5, 2020
Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors.
November 4, 2020
CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
November 4, 2020